Michael Ulz
Stock Analyst at Morgan Stanley
(3.31)
# 2,501
Out of 4,692 analysts
586
Total ratings
45.3%
Success rate
2.6%
Average return
Main Sectors:
Stocks Rated by Michael Ulz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARWR Arrowhead Pharmaceuticals | Reiterated: Buy | $120 | $86.73 | +38.36% | 28 | Sep 1, 2026 | |
| RYTM Rhythm Pharmaceuticals | Reiterated: Buy | $150 | $111.44 | +34.60% | 22 | Aug 25, 2026 | |
| CABA Cabaletta Bio | Rated: Buy | $13 | $3.10 | +319.35% | 22 | Aug 17, 2026 | |
| RCKT Rocket Pharmaceuticals | Rated: Hold | $5 | $3.53 | +41.64% | 19 | Aug 12, 2026 | |
| KYTX Kyverna Therapeutics | Rated: Buy | $33 | $8.24 | +300.49% | 24 | Aug 12, 2026 | |
| AARD Aardvark Therapeutics | Rated: Sell | $3 | $6.88 | -56.40% | 9 | Aug 12, 2026 | |
| SLN Silence Therapeutics | Rated: Buy | $25 → $32 | $13.29 | +140.78% | 34 | Aug 11, 2026 | |
| GUTS Fractyl Health | Rated: Hold | $2 | $0.75 | +166.67% | 18 | Aug 11, 2026 | |
| ZNTL Zentalis Pharmaceuticals | Maintained: Hold | $4 → $5 | $3.76 | +32.98% | 13 | Aug 7, 2026 | |
| BIOA BioAge Labs | Maintained: Hold | $23 → $20 | $9.38 | +113.22% | 16 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $25 | $18.13 | +37.89% | 31 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $150 → $137 | $96.72 | +41.65% | 25 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $27 → $25 | $9.91 | +152.27% | 24 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $400 → $300 | $236.01 | +27.11% | 47 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $47 → $45 | $25.99 | +73.14% | 25 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $110 | $62.04 | +77.30% | 39 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 | $33.23 | +185.89% | 25 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $0.6747 | +196.43% | 15 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $0.39 → $0.36 | $0.0001 | +359,900.00% | 13 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $9.19 | n/a | 8 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $2.44 | n/a | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $5 | $12.01 | n/a | 2 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $0.5 | $4.10 | n/a | 7 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.86 | n/a | 18 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.378 | n/a | 3 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $40 | $29.04 | n/a | 12 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $60 → $23 | $8.06 | n/a | 2 | May 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 | $5.97 | n/a | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $3 | $36.47 | n/a | 2 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $65.07 | n/a | 15 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.36 | n/a | 12 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $25.72 | n/a | 13 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $39.64 | n/a | 2 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $40.04 | n/a | 2 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $340 | $1,011.11 | n/a | 6 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $69 → $60 | $14.34 | n/a | 2 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $26.27 | n/a | 3 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 | $19.57 | n/a | 1 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $1.68 | n/a | 1 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $13.46 | n/a | 1 | Aug 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $8 | $0.0001 | n/a | 4 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $40 | $3.87 | n/a | 5 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $5.83 | n/a | 1 | Oct 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $146.74 | n/a | 1 | May 18, 2010 |
Arrowhead Pharmaceuticals
Sep 1, 2026
Reiterated: Buy
Price Target: $120
Current: $86.73
Upside: +38.36%
Rhythm Pharmaceuticals
Aug 25, 2026
Reiterated: Buy
Price Target: $150
Current: $111.44
Upside: +34.60%
Cabaletta Bio
Aug 17, 2026
Rated: Buy
Price Target: $13
Current: $3.10
Upside: +319.35%
Rocket Pharmaceuticals
Aug 12, 2026
Rated: Hold
Price Target: $5
Current: $3.53
Upside: +41.64%
Kyverna Therapeutics
Aug 12, 2026
Rated: Buy
Price Target: $33
Current: $8.24
Upside: +300.49%
Aardvark Therapeutics
Aug 12, 2026
Rated: Sell
Price Target: $3
Current: $6.88
Upside: -56.40%
Silence Therapeutics
Aug 11, 2026
Rated: Buy
Price Target: $25 → $32
Current: $13.29
Upside: +140.78%
Fractyl Health
Aug 11, 2026
Rated: Hold
Price Target: $2
Current: $0.75
Upside: +166.67%
Zentalis Pharmaceuticals
Aug 7, 2026
Maintained: Hold
Price Target: $4 → $5
Current: $3.76
Upside: +32.98%
BioAge Labs
Aug 7, 2026
Maintained: Hold
Price Target: $23 → $20
Current: $9.38
Upside: +113.22%
Aug 6, 2026
Rated: Hold
Price Target: $25
Current: $18.13
Upside: +37.89%
Aug 6, 2026
Rated: Buy
Price Target: $150 → $137
Current: $96.72
Upside: +41.65%
Aug 6, 2026
Rated: Buy
Price Target: $27 → $25
Current: $9.91
Upside: +152.27%
Jul 31, 2026
Maintained: Hold
Price Target: $400 → $300
Current: $236.01
Upside: +27.11%
Jul 31, 2026
Maintained: Buy
Price Target: $47 → $45
Current: $25.99
Upside: +73.14%
Jul 30, 2026
Maintained: Buy
Price Target: $110
Current: $62.04
Upside: +77.30%
Jul 30, 2026
Maintained: Buy
Price Target: $95
Current: $33.23
Upside: +185.89%
Jun 3, 2026
Reiterated: Buy
Price Target: $2
Current: $0.6747
Upside: +196.43%
Jan 8, 2026
Downgraded: Sell
Price Target: $0.39 → $0.36
Current: $0.0001
Upside: +359,900.00%
Mar 11, 2025
Maintained: Buy
Price Target: $5
Current: $9.19
Upside: n/a
Mar 6, 2025
Maintained: Hold
Price Target: $5
Current: $2.44
Upside: n/a
Feb 11, 2025
Downgraded: Hold
Price Target: $20 → $5
Current: $12.01
Upside: n/a
Aug 13, 2024
Maintained: Sell
Price Target: $0.5
Current: $4.10
Upside: n/a
Dec 15, 2023
Rated: Hold
Price Target: n/a
Current: $1.86
Upside: n/a
Dec 15, 2023
Rated: Hold
Price Target: n/a
Current: $0.378
Upside: n/a
Aug 22, 2023
Maintained: Hold
Price Target: $40
Current: $29.04
Upside: n/a
May 22, 2023
Rated: Buy
Price Target: $60 → $23
Current: $8.06
Upside: n/a
Jan 27, 2023
Downgraded: Hold
Price Target: $3
Current: $5.97
Upside: n/a
Jan 5, 2022
Maintained: Hold
Price Target: $7 → $3
Current: $36.47
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $65.07
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $1.36
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $25.72
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $39.64
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $40.04
Upside: n/a
Mar 4, 2021
Maintained: Buy
Price Target: $340
Current: $1,011.11
Upside: n/a
Mar 1, 2021
Maintained: Hold
Price Target: $69 → $60
Current: $14.34
Upside: n/a
Feb 16, 2021
Reiterated: Buy
Price Target: n/a
Current: $26.27
Upside: n/a
Jan 29, 2021
Maintained: Buy
Price Target: $37
Current: $19.57
Upside: n/a
Jan 29, 2021
Maintained: Buy
Price Target: $5
Current: $1.68
Upside: n/a
Aug 12, 2020
Initiated Coverage: Buy
Price Target: $45
Current: $13.46
Upside: n/a
Jul 30, 2020
Maintained: Buy
Price Target: $15 → $8
Current: $0.0001
Upside: n/a
Mar 28, 2019
Maintained: Hold
Price Target: $3 → $40
Current: $3.87
Upside: n/a
Oct 3, 2017
Rated: Buy
Price Target: n/a
Current: $5.83
Upside: n/a
May 18, 2010
Maintained: Buy
Price Target: $28
Current: $146.74
Upside: n/a